Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 16.96B 18.85B P/E ratio 2024 *
74.8x
P/E ratio 2025 * 45.9x
Enterprise value 19.24B 21.38B EV / Sales 2024 *
6.91x
EV / Sales 2025 * 6.27x
Free-Float
30.28%
Yield 2024 *
0.34%
Yield 2025 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.26%
1 week-4.10%
Current month-4.10%
1 month+2.65%
3 months-5.31%
6 months-31.74%
Current year-26.33%
More quotes
1 week
167.30
Extreme 167.3
183.60
1 month
164.20
Extreme 164.2
185.90
Current year
139.10
Extreme 139.1
281.00
1 year
139.10
Extreme 139.1
281.00
3 years
139.10
Extreme 139.1
551.00
5 years
120.60
Extreme 120.6
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Director TitleAgeSince
Chief Executive Officer 49 19-03-25
Chief Tech/Sci/R&D Officer 59 09-04-28
Investor Relations Contact 55 -
Manager TitleAgeSince
Chairman 59 07-06-28
Director/Board Member 62 07-06-28
Director/Board Member 63 15-04-06
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.12%-4.10%-32.76%-67.47%18.8B
-1.14%+0.30%+12.11%-12.28%197B
-1.80%+1.36%+11.46%-33.60%115B
-1.31%-3.20%-14.52%-9.53%67.42B
-2.94%-0.57%+36.66%+88.78%46.3B
-0.42%-7.02%+15.15%+6.51%46.57B
-0.08%-3.12%+14.03%-11.98%29.42B
-1.10%-0.82%-31.18%-49.08%27.67B
+0.04%-1.62%+20.99%+5.00%27.34B
-0.33%+0.56%+6.89%+9.75%23.57B
Average -0.78%-2.23%+3.88%-7.39% 59.85B
Weighted average by Cap. -1.15%-1.14%+8.01%-8.54%
See all sector performances
2024 *2025 *
Net sales 2.78B 3.09B 3.04B 3.38B
Net income 212M 236M 345M 384M
Net Debt 2.28B 2.53B 2.12B 2.36B
More financial data * Estimated data
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Employees
10,382
Calendar
More about the company
Date Price Change Volume
24-09-06 178.65 +2.53% 8,009
24-09-05 174.25 +0.46% 44,780
24-09-04 173.45 -0.72% 69,370
24-09-03 174.70 +0.55% 46,455
24-09-02 173.75 -5.57% 72,750

Real-time Euronext Paris, September 06, 2024 at 03:06 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
174.25EUR
Average target price
211.79EUR
Spread / Average Target
+21.54%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW